CTLA4 polymorphisms demonstrate significant pleiotropic effects, showing associations with multiple immune-mediated pathologies including systemic lupus erythematosus, rheumatoid arthritis, autoimmune diabetes, and allograft rejection episodes (31–33). Here, CTLA4 is linked to rheumatoid arthritis.